Industrial Manufacturing Process for 1-Acetoxy-4-Diethylamino-2-Butyne

• High-Yield Synthesis: Optimized acetylation of 4-diethylamino-2-butyn-1-ol ensures consistent reaction yields above 90%.
• Strict QC Protocols: Industrial purity standards exceed 98% with rigorous control over residual solvents and isomers.
• Bulk Availability: Scalable manufacturing process supports tonnage supply for global pharmaceutical demand.

1-Acetoxy-4-diethylamino-2-butyne (CAS: 22396-77-6) is a critical chemical building block in the pharmaceutical industry, primarily serving as a key Oxybutynin intermediate. The commercial viability of this compound depends heavily on a robust manufacturing process that balances cost-efficiency with stringent quality control. As demand for anticholinergic agents grows, manufacturers must ensure a stable supply of this high purity liquid while maintaining competitive bulk pricing. This technical overview details the synthesis route, impurity profiling, and scale-up considerations required for industrial production.

Overview of Acetylation Reaction Pathways

The primary synthesis route for producing 1-Acetoxy-4-diethylamino-2-butyne involves the esterification of 4-diethylamino-2-butyn-1-ol. This transformation is typically achieved using acetic anhydride as the acetylating agent in the presence of a tertiary amine base. Common catalytic systems include pyridine or 4-(dimethylamino)pyridine (DMAP), which facilitate the nucleophilic attack of the hydroxyl group on the anhydride.

Reaction conditions are maintained under inert atmosphere, often using nitrogen or argon, to prevent oxidation of the alkyne moiety. The process generally proceeds at temperatures ranging from 0°C to ambient conditions to minimize side reactions such as over-acetylation or polymerization. Upon completion, the reaction mixture is quenched with aqueous sodium bicarbonate or dilute acid to neutralize excess acetic acid and pyridine. The organic layer is then separated, washed, and dried over anhydrous magnesium sulfate or sodium sulfate.

For procurement teams evaluating suppliers, understanding the specific esterification method is vital. When sourcing high-purity 4-(Diethylamino)but-2-ynyl Acetate, buyers should verify that the manufacturer employs a refined workup procedure to remove amine residues. NINGBO INNO PHARMCHEM CO.,LTD. utilizes optimized catalytic cycles to ensure minimal downstream purification burden, resulting in a product suitable for immediate use in subsequent coupling reactions.

Impurity Control During Manufacturing Process

Achieving industrial purity requires meticulous attention to impurity profiles. The most common contaminants in this chemical building block include unreacted starting alcohol, acetic acid residues, and potential allene isomers formed during harsh conditions. Gas chromatography (GC) and high-performance liquid chromatography (HPLC) are standard analytical methods used to quantify these impurities.

Distillation is the critical step for final purification. Given the boiling point of approximately 217-218 °C at atmospheric pressure, vacuum distillation is preferred to reduce thermal stress on the molecule. Operating under reduced pressure (10-20 mmHg) allows for collection of the fraction at significantly lower temperatures, preserving the integrity of the alkyne bond. Manufacturers must also monitor for residual solvents such as tetrahydrofuran, dichloromethane, or ethyl acetate, ensuring they meet ICH Q3C guidelines.

Quality assurance protocols typically mandate a Certificate of Analysis (COA) with each batch. This document verifies parameters such as density (0.961 g/mL at 25 °C), refractive index, and assay purity. Consistent batch-to-batch variability is a major risk in organic synthesis; therefore, established producers implement strict in-process controls (IPC) to adjust reaction times and stoichiometry dynamically based on real-time data.

Scaling Synthesis Route from Lab to Industrial Production

Transitioning from laboratory scale to industrial production introduces challenges related to heat transfer, mixing efficiency, and safety. The exothermic nature of the acetylation reaction requires efficient cooling systems in large-scale reactors to prevent runaway temperatures. Additionally, the handling of acetic anhydride and tertiary amines necessitates robust ventilation and personal protective equipment (PPE) to mitigate respiratory and skin irritation risks.

Economies of scale significantly impact the bulk price of the final product. Large-volume manufacturers can leverage raw material procurement and continuous processing techniques to reduce costs. However, maintaining pharma grade standards during scale-up is non-negotiable. Equipment must be dedicated or thoroughly cleaned to prevent cross-contamination, especially when producing intermediates for regulated markets.

Global supply chains require manufacturers to maintain substantial inventory levels to meet just-in-time delivery schedules. As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. ensures capacity flexibility to accommodate fluctuating demand from API producers. The ability to supply tons of material while retaining high purity specifications distinguishes top-tier suppliers from smaller trading entities.

Property	Specification	Test Method
CAS Number	22396-77-6	Verification
Molecular Formula	C10H17NO2	Calculation
Molecular Weight	183.25 g/mol	Calculation
Appearance	Colorless to Light Yellow Liquid	Visual
Purity (GC)	> 98.0%	Gas Chromatography
Boiling Point	217-218 °C (lit.)	Distillation
Density	0.961 g/mL at 25 °C	Pychnometer

In conclusion, the production of 4-(Diethylamino)but-2-yn-1-yl acetate demands a sophisticated understanding of esterification chemistry and process engineering. By prioritizing impurity control and scalable reaction conditions, manufacturers can deliver a reliable supply of this essential intermediate. Partnering with an experienced supplier ensures that technical specifications are met consistently, supporting the efficient production of downstream pharmaceutical products.